Anders joined Novo Holdings A/S in May 2017 as Senior Director, Principal Investments, taking part in managing and developing the growing portfolio of investments.

Prior to joining Novo Holdings, Anders was employed as Vice President in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include Executive Vice President, Global Product Supply at Leo Pharma A/S and Vice President Global Supply Chain at Novozymes A/S.

Anders holds a Ph.D. in Biotechnology and a M.Sc in Chemical Engineering from Technical University of Denmark as well as degree in international commerce from Copenhagen Business School.